ArticleCureus2026
Totally Endoscopic Minimally Invasive Aortic Valve Replacement Under Near Normothermia in a Patient With Cryoglobulinemia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac surgery in patients with cryoglobulinemia remains challenging because perioperative hypothermia may increase the risk of cryoglobulin-related complications. We report the case of a 49-year-old man with severe bicuspid aortic valve stenosis and preoperatively confirmed cryoglobulinemia who underwent totally endoscopic minimally invasive aortic valve replacement without preoperative plasmapheresis. The patient had no clinical manifestations of cryoglobulinemic vasculitis, and extensive hematologic and immunologic evaluation demonstrated no monoclonal gammopathy, a normal serum free light chain ratio, and negative viral and autoimmune markers. Because the patient was considered low risk for cryoglobulin-related complications, surgery was successfully performed using normothermic cardiopulmonary bypass with intermittent tepid blood cardioplegia, while maintaining a lowest core temperature of 34.8 °C. The postoperative course was uneventful, with no evidence of cryoglobulin-related complications. This case suggests that, in carefully selected low-risk patients without active vasculitic manifestations, minimally invasive cardiac surgery under strict normothermic management may be feasible without routine preoperative plasmapheresis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.